Hepatic encephalopathy treated with L-dopa, recovery followed for 18 months.
D000293:Adolescent; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D007441:Intubation, Gastrointestinal
D004295:Dihydroxyphenylalanine